For sustainable economic growth and development, energy security of a nation is of utmost importance. We are witnessing countries across the globe striving to be energy secure. At the same time, India has been struggling to become an 'Energy Secure' nation.
The main objective of this paper is to highlight how important it is for companies to proactively manage risk in the delivery of their capital projects to ensure that capital projects are completed on time and to budget.
The socioeconomic benefits of advanced telecommunications infrastructure and services are intuitive, as well as definitive. Arthur D. Little studies have demonstrated the links between advanced telecommunications and the diversity and strength of economies.
Excellent customer service is a critical success factor for businesses across all industries. But how many organisations can really claim to be giving fantastic, WOW factor customer service across all customer touch points?
Arthur D. Little have produced a major study concerning future innovation in the food and drink industry for Defra, the United Kingdom Government’s Department for Food and Rural Affairs. The study seeks to identify opportunities for more sustainable, healthier food and drink production.
The Internet economy remains one of the main growth drivers of the German economy with a projected growth rate of over 11% per year until 2016. Thereby the German internet economy is becoming a crucial job engine for Germany. In this study, conducted for the second time since 2009 together with...
Mid-sized upstream oil and gas companies often make relatively low investments in technology development and lack the leverage over service and equipment companies that is held by the larger E&P companies. In this viewpoint, Arthur D.
“The dynamics of online competition are affecting the gas and power retail markets. The number of different offers, their widespread accessibility and increasing energy costs has caused a transformation in customers' behavior that is already noticeable in other industries.
After years of low productivity, R&D in leading pharmaceutical and biotech companies is starting to deliver on its promises and the number of New Molecular Entities (NMEs) approved by the US FDA has leveled out. Once approval has been gained there needs to be a launch.